ZYROP 4000IU INJECTION

Zyrop 4000IU Injection is a recombinant erythropoietin therapy designed to treat anemia associated with chronic kidney disease, dialysis, and chemotherapy. It contains erythropoietin alfa, which stimulates red blood cell production in the bone marrow, helping restore hemoglobin levels and improve oxygen delivery throughout the body. This pharmaceutical product is administered under medical supervision for safe and effective anemia management.

Zyrop 4000IU Injection is commonly prescribed to patients experiencing fatigue, weakness, and shortness of breath due to low red blood cell counts. It helps reduce the need for blood transfusions while supporting overall energy and well-being. Regular monitoring of hemoglobin levels ensures optimal dosing and therapeutic outcomes.

Zyrop 4000IU Injection guarantees purity, potency, and consistent therapeutic performance. This injectable product is widely supplied to hospitals, nephrology clinics, and global pharmaceutical markets, providing reliable anemia management solutions.

Product Features

• Contains Erythropoietin Alfa 4000 IU
• Stimulates natural red blood cell production
• Used for CKD and chemotherapy-induced anemia
• Helps minimize blood transfusion requirements
• High-quality sterile injectable formulation

How It Helps

• Raises hemoglobin levels safely
• Improves oxygen supply to tissues
• Reduces fatigue and weakness
• Supports long-term anemia control